Tag: COVID-19

Timing of major surgery after COVID-19 affects postop mortality

Editor's Note This study led by researchers at State University of New York Downstate Health Sciences University, Brooklyn, finds that patients having major surgical procedures within 8 weeks of a COVID-19 infection have a substantially higher postoperative 90-day mortality, regardless of symptoms. Analyzing data on 938 COVID-19 positive patient cases…

Read More

By: Judy Mathias
August 17, 2022
Share

80% of HCWs at California hospital exposed to COVID-19, showing symptoms test positive

Editor's Note Some 80% of healthcare workers (HCWs) at Sonoma Valley Hospital, Sonoma, California, exposed to COVID-19  or showing symptoms, tested positive the last 2 weeks of  July, the August 15 Sonoma Index-Tribune reports. A total of 97% of HCWs are fully vaccinated, and the remaining 3% have valid exemptions.…

Read More

By: Judy Mathias
August 17, 2022
Share

COVID-19 risk among HCWs according to patient exposure, mask type

Editor's Note This study from Switzerland finds that COVID-19 positivity in healthcare workers (HCWs) was associated with cumulative patient exposure, which could be modulated with the use of respirator masks. Of 2,919 HCWs included in the study, 749 were infected with COVID-19. Positivity was 13% in HCWs without patient exposure.…

Read More

By: Judy Mathias
August 16, 2022
Share

Seven schools, hospitals starting new nursing programs

Editor's Note Seven schools and hospitals have added nursing programs and partnerships to help tackle the US nursing shortage, the August 10 Becker’s Hospital Review reports. LSU Health New Orleans’ School of Nursing will offer three accelerated courses, beginning in January 2023. University of New Mexico, Albuquerque, is constructing a…

Read More

By: Judy Mathias
August 16, 2022
Share

Maternal morbidity associated with delivery during COVID-19

Editor's Note This retrospective cohort study led by researchers at Ascension Health, St Louis, finds that COVID-19 infection is a risk factor for adverse peripartum maternal outcomes. Researchers evaluated the association of COVID-19 with severe maternal morbidities in patients delivering during four pandemic periods characterized by predominant variants—March-December 2020 (wild…

Read More

By: Judy Mathias
August 15, 2022
Share

CDC updates COVID-19 guidance

Editor's Note The Centers for Disease Control and Prevention (CDC) on August 11 updated its guidelines for COVID-19. The new recommendations focus on helping people better understand their risks, how to protect themselves and others, what actions to take if exposed, and what actions to take if they test positive…

Read More

By: Judy Mathias
August 15, 2022
Share

Simple new test predicts immunity to COVID-19

Editor's Note Researchers from the Massachusetts Institute of Technology, Cambridge, have developed a simple new paper test that can measure the level of neutralizing antibodies in a blood sample. Using the same type of lateral flow technology that rapid antigen tests use, the new test is designed so that different…

Read More

By: Judy Mathias
August 11, 2022
Share

Immune response of mix-and-match boosters

Editor's Note This study led by researchers at Beth Israel Deaconess Medical Center, Boston, finds that being boosted with either the Janssen (Johnson & Johnson) or Pfizer-BioNTech vaccine was associated with increased humoral and cellular immune responses. Boosting with the Janssen vaccine also was associated with durable antibody and T-cell…

Read More

By: Judy Mathias
August 11, 2022
Share

Recovery of smell, taste after COVID-19 may take 6 months

Editor's Note This meta-analysis led by researchers at the National University of Singapore finds that recovery of the ability to taste and smell after COVID-19 infection may take up to 6 months, and women are more likely to experience loss of these senses and have a longer time to recovery.…

Read More

By: Judy Mathias
August 10, 2022
Share

FDA: Class I recall of Haimen Shengbang Viral Transport Media Containers

Editor's Note The Food and Drug Administration (FDA) on August 9 identified the recall by Haimen Shengbang Laboratory Equipment Co Ltd of its Viral Transport Media Containers as Class I, the most serious. The recall was initiated because the products were distributed in the US without authorization, clearance, or approval…

Read More

By: Judy Mathias
August 10, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat